CS232726B2 - Method of making pure surface hepatitide b antigene from human plasma - Google Patents

Method of making pure surface hepatitide b antigene from human plasma Download PDF

Info

Publication number
CS232726B2
CS232726B2 CS824254A CS425482A CS232726B2 CS 232726 B2 CS232726 B2 CS 232726B2 CS 824254 A CS824254 A CS 824254A CS 425482 A CS425482 A CS 425482A CS 232726 B2 CS232726 B2 CS 232726B2
Authority
CS
Czechoslovakia
Prior art keywords
plasma
antigen
human plasma
proteins
protein
Prior art date
Application number
CS824254A
Other languages
Czech (cs)
English (en)
Other versions
CS425482A2 (en
Inventor
Witold Brzosko
Piotr Janicki
Zbigniew K Laskowski
Kazimierz Madalinski
Andrzej Dabrowa
Original Assignee
Akad Medyczna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akad Medyczna filed Critical Akad Medyczna
Publication of CS425482A2 publication Critical patent/CS425482A2/cs
Publication of CS232726B2 publication Critical patent/CS232726B2/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CS824254A 1981-06-10 1982-06-08 Method of making pure surface hepatitide b antigene from human plasma CS232726B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL1981231588A PL133476B1 (en) 1981-06-10 1981-06-10 Method of obtaining pure antigen hba from human serum

Publications (2)

Publication Number Publication Date
CS425482A2 CS425482A2 (en) 1984-06-18
CS232726B2 true CS232726B2 (en) 1985-02-14

Family

ID=20008812

Family Applications (1)

Application Number Title Priority Date Filing Date
CS824254A CS232726B2 (en) 1981-06-10 1982-06-08 Method of making pure surface hepatitide b antigene from human plasma

Country Status (22)

Country Link
US (1) US4558011A (ko)
JP (1) JPS584729A (ko)
AU (1) AU8471282A (ko)
CA (1) CA1203169A (ko)
CH (1) CH650682A5 (ko)
CS (1) CS232726B2 (ko)
DD (1) DD202506A5 (ko)
DE (1) DE3221813A1 (ko)
DK (1) DK260482A (ko)
ES (1) ES8303916A1 (ko)
FI (1) FI822018A0 (ko)
FR (1) FR2507478A1 (ko)
GB (1) GB2099700B (ko)
HU (1) HU186864B (ko)
IT (1) IT1151793B (ko)
NO (1) NO821927L (ko)
PL (1) PL133476B1 (ko)
PT (1) PT75031B (ko)
RO (1) RO84231B (ko)
SE (1) SE8203435L (ko)
SU (1) SU1409121A3 (ko)
YU (1) YU116882A (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683294A (en) * 1985-04-03 1987-07-28 Smith Kline Rit, S.A. Process for the extraction and purification of proteins from culture media producing them
US4742158A (en) * 1986-04-25 1988-05-03 Merck & Co., Inc. Purification of hepatitis pre-S antigens by polymerized serum albumin affinity binding
US5242812A (en) * 1989-02-07 1993-09-07 Bio-Technology General Corp. Method for production and purification of hepatitis B vaccine
GB9822714D0 (en) * 1998-10-16 1998-12-09 Smithkline Beecham Sa Vaccines

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636191A (en) * 1969-10-08 1972-01-18 Cancer Res Inst Vaccine against viral hepatitis and process
DE2225548C3 (de) * 1972-05-26 1980-05-29 Behringwerke Ag, 3550 Marburg Intravenös verträglicher Impfstoff gegen Staupe- und Hepatite contagiosa canis
FR2303562A1 (fr) * 1975-03-14 1976-10-08 Community Blood Council Greate Nouvelle preparation d'antigene utilisable comme vaccin
US4017360A (en) * 1975-05-14 1977-04-12 Merck & Co., Inc. Method for purifying hepatitis B antigen
SE420977B (sv) * 1976-03-18 1981-11-16 Kabi Ab Forfarande for rening och isolering av hepatitvirus for vaccinframstellning
SU810811A1 (ru) * 1979-02-19 1981-03-07 Институт Полиомиелита И Вирусныхэнцефалитов Amh Cccp Способ получени вируса гепатитаА

Also Published As

Publication number Publication date
RO84231A (ro) 1984-05-23
DK260482A (da) 1982-12-11
HU186864B (en) 1985-10-28
DD202506A5 (de) 1983-09-21
PT75031B (en) 1984-05-09
PT75031A (en) 1982-07-01
AU8471282A (en) 1982-12-16
RO84231B (ro) 1984-07-30
PL231588A1 (ko) 1982-12-20
NO821927L (no) 1982-12-13
JPS584729A (ja) 1983-01-11
US4558011A (en) 1985-12-10
FR2507478A1 (fr) 1982-12-17
SU1409121A3 (ru) 1988-07-07
ES512971A0 (es) 1983-02-16
DE3221813A1 (de) 1983-02-17
CH650682A5 (de) 1985-08-15
GB2099700B (en) 1984-12-19
CS425482A2 (en) 1984-06-18
FR2507478B1 (ko) 1984-09-07
FI822018A0 (fi) 1982-06-07
GB2099700A (en) 1982-12-15
CA1203169A (en) 1986-04-15
ES8303916A1 (es) 1983-02-16
YU116882A (en) 1985-03-20
SE8203435L (sv) 1982-12-11
IT1151793B (it) 1986-12-24
PL133476B1 (en) 1985-06-29
IT8221787A0 (it) 1982-06-09

Similar Documents

Publication Publication Date Title
US4683294A (en) Process for the extraction and purification of proteins from culture media producing them
US3636191A (en) Vaccine against viral hepatitis and process
JPH0331691B2 (ko)
DK145347B (da) Fremgangsmaade til rensning af hepatitis b antigen
JPS6078999A (ja) ＨＢｓ抗原の精製方法
WO1984001289A1 (en) Purified and antigenically selective vaccines for domestic animals
JP4523164B2 (ja) ワクチン
CS232726B2 (en) Method of making pure surface hepatitide b antigene from human plasma
RU2089216C1 (ru) Способ удаления эндотоксина из культуральной жидкости штамма фазы i bordetella pertussis
EP0112506A2 (en) A process for producing a hepatitis B infection preventing vaccine
AU605901B2 (en) Purification process
JPH0236193A (ja) マイコプラズマ・ニユーモニエからの１６８ｋＤタンパク質の精製法
BG100212A (bg) Метод за пречистване на повърхностен антиген на вируса на хепатит в, съдържащ пептида pres2
EP0339668A2 (en) Hepatitis A virus antigen
IL23187A (en) Production of vaccines
KR100194247B1 (ko) 재조합 b형 간염 표면 항원의 정제방법
RU2120804C1 (ru) Способ приготовления вакцины против клещевого или японского энцефалита из вирусной суспензии
RU2084229C1 (ru) Способ получения иммуноглобулинового препарата для профилактики и терапии бактериальных и вирусных заболеваний
US3477911A (en) Method of production of urokinase
US3477910A (en) Method of production of urokinase
RU2128508C1 (ru) Способ получения иммуноглобулинов
RU2073525C1 (ru) Способ получения иммуноглобулинового препарата
RU2158137C1 (ru) Способ получения иммуноглобулинового препарата
CN87106697A (zh) 制备乙型肝炎复合疫苗的方法
SU1017339A1 (ru) Способ получени эритроцитарного диагностикума